McCulloch Kevin
Insider CIK 2031695 · XERS See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, | S Sale | 2026-10-01 | 2026-10-02 | 15,000 | $9.41 | $141.1K | 1,599,208 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-09-28 | 2026-09-29 | 25,000 | $10.00 | $250.0K | 1,614,208 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-09-28 | 2026-09-29 | 25,000 | $10.00 | $250.0K | 1,614,208 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-09-01 | 2026-09-01 | 15,000 | $8.49 | $127.3K | 1,639,208 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-09-01 | 2026-09-01 | 15,000 | $8.49 | $127.3K | 1,639,208 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-08-03 | 2026-08-04 | 15,000 | $8.02 | $120.3K | 1,676,126 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-08-03 | 2026-08-04 | 15,000 | $8.02 | $120.2K | 1,676,126 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-08-01 | 2026-08-21 | 21,918 | $8.08 | $177.1K | 1,654,208 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-08-01 | 2026-08-21 | 21,918 | $8.08 | $177.1K | 1,654,208 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-07-01 | 2026-07-02 | 90,000 | $8.03 | $722.7K | 1,691,126 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2026-03-12 | 2026-03-16 | 48,894 | $4.09 | $200.0K | 43,773 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2026-03-12 | 2026-03-16 | 4 | $3.94 | $16 | 79,996 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2026-03-12 | 2026-03-16 | 4 | $3.94 | $16 | 1,777,725 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2026-03-12 | 2026-03-16 | 48,894 | $4.09 | $200.0K | 1,777,721 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 27,319 | $7.36 | $201.1K | 1,727,827 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 68,454 | $7.36 | $503.8K | 1,785,435 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 30,289 | $7.36 | $222.9K | 1,755,146 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2026-01-30 | 2026-02-02 | 225,225 | — | $0 | 225,225 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2026-01-30 | 2026-02-02 | 168,463 | — | $0 | 1,853,889 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-01-08 | 2026-01-09 | 15,000 | $8.00 | $120.0K | 1,685,426 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-10-02 | 2025-10-03 | 733 | $8.31 | $6.1K | 1,700,426 | SEC↗ |
| XERS Xeris Biopharma Holdings, | J Other | 2025-09-11 | 2025-09-15 | 2,000 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-08-01 | 2025-08-04 | 14,651 | $5.38 | $78.8K | 1,701,159 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2025-06-13 | 2025-06-16 | 25,000 | $4.38 | $109.5K | 1,708,585 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-04-02 | 2025-04-03 | 733 | $5.15 | $3.8K | 1,683,585 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2025-01-31 | 2025-02-03 | 500,000 | — | $0 | 500,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2025-01-31 | 2025-02-03 | 185,000 | — | $0 | 1,684,318 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 29,300 | $3.56 | $104.3K | 1,548,152 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 48,834 | $3.56 | $173.8K | 1,499,318 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-03 | 2025-01-07 | 24,501 | $3.61 | $88.4K | 1,577,452 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2024-08-01 | 2024-08-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-08-01 | 2024-08-02 | 150,000 | — | $0 | 1,601,953 | SEC↗ |